Related Experiment Videos
Modulation of N-methyl-D-aspartate receptor function by glycine transport
R Bergeron1, T M Meyer, J T Coyle
1Laboratory of Neuroscience, Department of Psychiatry, Harvard Medical School, 115 Mill Street, Belmont, MA 02178-9106, USA.
Summary
Glycine transporters (GLYT1) control N-methyl-D-aspartate receptor (NMDAR) function by regulating glycine levels. Blocking GLYT1 enhances NMDAR activity, suggesting therapeutic potential for NMDAR-related disorders.
Area of Science:
- Neuroscience
- Neuropharmacology
- Molecular Biology
Background:
- Glycine transporters, particularly glycine transporter type 1 (GLYT1), are present in the central nervous system and periphery.
- Glycine transport is hypothesized to regulate N-methyl-D-aspartate receptor (NMDAR) function by controlling glycine concentration at the NMDAR modulatory glycine site.
Purpose of the Study:
- To investigate the role of GLYT1 in modulating NMDAR function in hippocampal pyramidal neurons.
- To determine if GLYT1 inhibition enhances NMDAR activity under physiological glycine concentrations.
Main Methods:
- Whole-cell patch-clamp recordings were performed on hippocampal pyramidal neurons in vitro.
- Exogenous glycine and a selective GLYT1 antagonist were applied to assess their effects on NMDAR-mediated currents.
- Specific antagonists (2-amino-5-phosphonovaleric acid, 7-chloro-kynurenic acid, strychnine) were used to confirm the NMDAR component.
Main Results:
- Exogenous glycine and GLYT1 antagonist selectively enhanced the NMDA component of glutamatergic excitatory postsynaptic currents.
- The observed enhancement was blocked by NMDA receptor antagonists but not by strychnine, indicating glycine site involvement.
- GLYT1 antagonism increased NMDAR function even with physiological glycine concentrations (10 microM), supporting subsaturating glycine levels in vivo.
Conclusions:
- GLYT1 actively maintains a subsaturating concentration of glycine at synaptically activated NMDARs.
- Inhibition of GLYT1 enhances NMDAR function, presenting a potential therapeutic strategy for conditions associated with NMDAR hypofunction.